Safety and Maintenance Study of Entocort for Children With Crohn's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Crohn's Disease
Interventions
DRUG

Entocort

Entocort capsules, taken orally, 6 mg daily.

Trial Locations (19)

Unknown

Research Site, Atlanta

Research Site, Oak Lawn

Research Site, Newton

Research Site, Saint Paul

Research Site, Mays Landing

Research Site, Buffalo

Research Site, Houston

Research Site, Halifax

Research Site, London

Research Site, München

Research Site, Nuremberg

Research Site, Florence

Research Site, Messina

Research Site, Roma

Research Site, Krakow

Research Site, Lodz

Research Site, Rzeszów

Research Site, Warsaw

Research Site, Wroclaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Padagis LLC

INDUSTRY

NCT01453946 - Safety and Maintenance Study of Entocort for Children With Crohn's Disease | Biotech Hunter | Biotech Hunter